Atomoxetine maintenance treatment in preventing ADHD relapse.

The article focuses on the randomized, double-blind trial that compares the efficacy of atomoxetine and placebo to prevent relapse in a group of children with attention-deficit hyperactivity disorder (ADHD) in the U.S. The study revealed that atomoxetine shows positive response towards the treatment of children with ADHD. Researchers believe that long-term medication of atomoxetine will help lessen the symptoms of the disease.